Ascidian Therapeutics to Present Data From Its Lead Program Targeting ABCA4 Retinopathies at the Retinal Cell and Gene Therapy Innovation Summit and ARVO 2023 Annual Meeting

/PRNewswire/ -- Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today that Chief Medical Officer...

Related Keywords

Oregon ,United States ,Boston ,Massachusetts ,Jay Barth ,Shimyn Slomovic ,Romesh Subramanian ,Orleans Ernestn Morial Convention Center ,Foundation Fighting Blindness ,Oregon Health Science University ,Casey Eye Institute ,Association For Research ,Chief Medical Officer Jay Barth ,Eighth Annual Retinal Cell ,Gene Therapy Innovation Summit ,Molecular Biology Shimyn Slomovic ,Retinal Cell ,Chief Executive Officer ,Oregon Health ,Science University ,Friday April ,Marriott New Orleans Warehouse Arts District ,New Orleans ,Presentation Number ,New Orleans Ernest ,Convention Center ,Ascidian Therapeutics ,Health Care Amp Hospitals ,Biotechnology ,Medical Pharmaceuticals ,Trade Show News ,Clinical Trials Amp Medical Discoveries ,